Services Kirkstall’s Quasi VivoTM system is accessible to both industrial and academic partners on a contract research basis. In collaboration with Agenda1 Analytical Ltd. (link) Kirkstall can support fully regulated in-house testing of drug candidates or disease models in our own laboratory.
Our advanced tissue culture system in combination with our expertise in cell culture and tissue engineering can provide you with invaluable in vitro pharmacological support throughout the drug discovery process. From early development, to lead identification through to preclinical safety, our technology and expertise can help. The high quality screening of Kirkstall’s Quasi Vivo TM system can help reduce the bottleneck from High throughput screening to in vivo preclinical trails by identifying compounds that are likely to fail in the later stages of trials.
Based on your stage of development we can advise on the most relevant assays and the selection of tissues or cells used for screening. Please contact our Business Development Manager to discuss any of your contract research requirements, confidentially and without obligation. for more information download the Contract Research pdf
|
